Medical News

---

• Smoking rates high among bipolar disorder patients
• Anticoagulants ‘underused’ in pacemaker patients
• VTE burden ‘significant’ in patients with cirrhosis
• Antipsychotic drugs increase cardiovascular disease risk
• Symptomatic ICH has limited impact on prognosis after stroke thrombolysis
• Antipsychotic drugs increase cardiovascular disease risk
• High fiber intake and increased exercise may reduce abdominal fat
• Statin therapy for primary prevention is ‘cost-effective’
• VTE burden ‘significant’ in patients with cirrhosis
• Extended-release exenatide may reduce CV event risk
• Telomere length predicts diabetic complication risk

Smoking rates high among bipolar disorder patients Posted: 04 Jul 2011 05:00 PM PDT Bipolar disorder patients are more likely to smoke than the general population, with moderate and heavy smokers more likely to consume alcohol and abuse psychoactive substances than nonsmokers, say Israeli researchers.

Anticoagulants ‘underused’ in pacemaker patients Posted: 04 Jul 2011 05:00 PM PDT Spanish researchers report that many patients with pacemakers have atrial fibrillation or atrial flutter, and yet are undertreated for the prevention of thromboembolism.

VTE burden ‘significant’ in patients with cirrhosis Posted: 03 Jul 2011 05:00 PM PDT A substantial proportion of patients with cirrhosis are hospitalized with venous thromboembolism throughout the year, US study data show.

Antipsychotic drugs increase cardiovascular disease risk Posted: 03 Jul 2011 05:00 PM PDT The increase in cardiovascular risk associated with schizophrenia appears to be due to treatment with antipsychotic drugs, rather than the disease itself, a systematic review of studies into first treated episodes of psychosis reveals.

Symptomatic ICH has limited impact on prognosis after stroke thrombolysis Posted: 03 Jul 2011 05:00 PM PDT Symptomatic intracerebral hemorrhage contributes to poor outcomes in patients who undergo stroke thrombolysis, but is less important than factors such as age and stroke severity, say researchers.

Antipsychotic drugs increase cardiovascular disease risk Posted: 03 Jul 2011 05:00 PM PDT The increase in cardiovascular risk associated with schizophrenia appears to be due to treatment with antipsychotic drugs, rather than the disease itself, a systematic review of studies into first treated episodes of psychosis reveals.

High fiber intake and increased exercise may reduce abdominal fat Posted: 03 Jul 2011 05:00 PM PDT Increased soluble fiber intake and participation in vigorous activity are associated with a decreased rate of accumulated visceral fat, suggests an analysis of the IRAS Family Study.

Statin therapy for primary prevention is ‘cost-effective’ Posted: 03 Jul 2011 05:00 PM PDT Aggressive statin treatment guidelines that target patients with modestly elevated low-density lipoprotein cholesterol or any coronary heart disease risk factors are cost-effective, as long as patients are willing to take a daily pill, say US researchers.

VTE burden ‘significant’ in patients with cirrhosis Posted: 03 Jul 2011 05:00 PM PDT A substantial proportion of patients with cirrhosis are hospitalized with venous thromboembolism throughout the year, US study data show.

Extended-release exenatide may reduce CV event risk Posted: 03 Jul 2011 05:00 PM PDT A once-weekly formulation of the glucagon-like peptide, exenatide, may decrease cardiovascular event risk in patients with Type 2 diabetes through combined effects on various risk factors, modeling of NHANES data suggests.

Telomere length predicts diabetic complication risk Posted: 03 Jul 2011 05:00 PM PDT Telomere length appears to be strongly predictive of the presence and number of complications associated with Type 2 diabetes, report researchers who say telomere measurement could be a useful part of standard disease management.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610